Albaad (ALBA) AI Stock Analysis

• Market Cap: 654.34M
• Dividend Yield: 3.09%
• Average Volume (3M): 16.36K
• Price to Earnings (P/E): 11.6
• Beta (1Y): 0.50
• Revenue Growth: 1.75%
• EPS Growth: 5.26%
• Country: IL
• Employees: 1,670
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Household & Personal Products
• EPS (TTM): N/A
• Shares Outstanding: 18,647,507
• 10 Day Avg. Volume: 13,562
• 30 Day Avg. Volume: 16,359
• PEG Ratio: 0.16
• Price to Book (P/B): 0.84
• Price to Sales (P/S): 0.21
• P/FCF Ratio: 3.55
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 73 Outperform
• Price Target: 3,913.00 ▲(7.68% Upside)

Albaad's stock is supported by strong technical indicators and an attractive valuation, suggesting potential for price appreciation. However, financial performance is hindered by high leverage and declining cash flow, which are risks that need to be managed.

Positive Factors

Robust revenue growth

A 49.3% TTM revenue increase reflects durable demand expansion and successful commercial execution across channels. Sustained top-line growth supports scale economics, capacity utilization, and long-term contract leverage, enabling reinvestment in product and geographic expansion.

Diversified business model

Broad product mix (feminine, baby, adult care) and long-term contracts with retailers and partners reduce single-market risk. Diversification across products and geographies supports steady demand, resilience to cyclical shocks, and sustained cash flow visibility over a multi‑month horizon.

Improving profitability metrics

Improved ROE and near-20% gross margins signal better cost control and pricing power in core products. Persistent margin improvement increases ability to fund capex and R&D, enhancing long-term competitiveness and shareholder returns if maintained across business cycles.

Negative Factors

High financial leverage

A D/E of 1.49 implies elevated interest and refinancing risk, constraining strategic flexibility. Over the next several months higher leverage can amplify earnings volatility, limit capacity for opportunistic investment, and increase sensitivity to cost or demand shocks.

Declining free cash flow

A nearly 39% drop in FCF growth reduces the company’s ability to deleverage, fund capex, or increase shareholder distributions. Weakening cash generation versus reported earnings raises concerns about earnings quality and the sustainability of reinvestment and growth plans.

Poor cash conversion

Low OCF-to-income (0.215) indicates earnings are not well backed by cash, risking liquidity under stress. Subpar cash conversion limits buffer for working capital swings, elevates dependency on external funding, and weakens resilience to margin pressure over the medium term.

Albaad Business Overview & Revenue Model

Company Description

Albaad Massuot Yitzhak Ltd produces and sells wipes worldwide. It offers cleaning hand wipes including disinfecting and antibacterial wipes; cosmetic wipes, such as facial care, body, and feet care wipes; feminine hygienic product, which include tampons; and baby, maternity, toddler, and household cleaning wipes. The company also provides professional wipes, such as para-medical, veterinary, automotive, and restaurant wipes, as well as sachets; adult wipes including adult bed and bath; personal care wipes, which include intimate wipes; para-pharma wipes and flushable moist toilet paper product. In addition, it offers contract, private label, and institutional manufacturing services. The company was founded in 1985 and is based in Nir Yitzhak, Israel.

How the Company Makes Money

Albaad generates revenue through multiple key streams, primarily by manufacturing and selling nonwoven fabric hygiene products to various retailers, wholesalers, and distributors. The company benefits from long-term contracts with major brands, ensuring a steady flow of income. Additionally, Albaad invests in research and development to create innovative products that cater to changing consumer preferences, which allows them to maintain a competitive edge. Partnerships with leading companies in the personal care industry further enhance their market reach and profitability. The company also focuses on sustainability initiatives, which not only attract environmentally-conscious consumers but may provide cost savings in production, contributing positively to their earnings.

Albaad Financial Statement Overview

Summary

Albaad shows a positive growth trajectory with a significant revenue increase and improved net profit margin. However, high leverage and declining free cash flow growth present risks. Operational efficiency and debt management are areas for improvement.

Income Statement

Albaad's income statement shows a positive trajectory with a significant revenue growth rate of 29.3% in the TTM period. The gross profit margin is stable at around 20%, and the net profit margin has improved to 2.93% from previous negative figures. However, the EBIT and EBITDA margins are moderate, indicating room for operational efficiency improvements.

Balance Sheet

The balance sheet reveals a high debt-to-equity ratio of 1.49, indicating significant leverage, although it has improved from previous years. The return on equity has increased to 11.44%, reflecting better profitability. The equity ratio remains stable, suggesting a balanced asset structure, but the high leverage poses potential risks.

Cash Flow

Cash flow analysis shows a decline in free cash flow growth by 20.29% in the TTM period, which is concerning. The operating cash flow to net income ratio is low at 0.22, indicating limited cash conversion efficiency. However, the free cash flow to net income ratio of 0.61 suggests some level of cash generation capability.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	1.76B	1.72B	1.71B	1.45B	1.49B	1.58B
Gross Profit	351.40M	347.93M	344.37M	235.00M	270.70M	418.70M
EBITDA	202.17M	192.42M	176.03M	78.18M	192.56M	281.40M
Net Income	56.21M	44.88M	30.23M	-35.12M	-20.34M	101.31M
Balance Sheet
Total Assets	1.53B	1.51B	1.58B	1.60B	1.57B	1.41B
Cash, Cash Equivalents and Short-Term Investments	8.48M	25.16M	19.13M	27.19M	18.24M	34.05M
Total Debt	688.71M	712.92M	829.03M	836.53M	802.11M	609.00M
Total Liabilities	1.06B	1.07B	1.18B	1.24B	1.14B	927.61M
Stockholders Equity	464.93M	426.68M	394.08M	346.83M	430.25M	478.58M
Cash Flow
Free Cash Flow	52.37M	101.60M	120.98M	-67.58M	-38.08M	114.28M
Operating Cash Flow	116.99M	152.50M	233.23M	18.57M	52.58M	184.72M
Investing Cash Flow	-25.02M	-9.51M	-110.94M	-30.36M	-170.24M	-22.61M
Financing Cash Flow	-110.10M	-135.56M	-134.49M	20.46M	103.68M	-149.09M

Albaad Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 3634.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:ALBA, the sentiment is Positive. The current price of 3634 is above the 20-day moving average (MA) of 3434.75, above the 50-day MA of 3066.80, and above the 200-day MA of 2318.69, indicating a bullish trend. The MACD of 144.71 indicates Positive momentum. The RSI at 57.71 is Neutral, neither overbought nor oversold. The STOCH value of 34.31 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IL:ALBA.

Albaad Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ALBA	73 Outperform	654.34M	11.64	―	3.09%	1.75%	5.26%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%